Computational analysis of peripheral blood smears detects disease-associated cytomorphologies.
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
20 07 2023
20 07 2023
Historique:
received:
27
04
2022
accepted:
22
06
2023
medline:
23
10
2023
pubmed:
21
7
2023
entrez:
20
7
2023
Statut:
epublish
Résumé
Many hematological diseases are characterized by altered abundance and morphology of blood cells and their progenitors. Myelodysplastic syndromes (MDS), for example, are a group of blood cancers characterised by cytopenias, dysplasia of hematopoietic cells and blast expansion. Examination of peripheral blood slides (PBS) in MDS often reveals changes such as abnormal granulocyte lobulation or granularity and altered red blood cell (RBC) morphology; however, some of these features are shared with conditions such as haematinic deficiency anemias. Definitive diagnosis of MDS requires expert cytomorphology analysis of bone marrow smears and complementary information such as blood counts, karyotype and molecular genetics testing. Here, we present Haemorasis, a computational method that detects and characterizes white blood cells (WBC) and RBC in PBS. Applied to over 300 individuals with different conditions (SF3B1-mutant and SF3B1-wildtype MDS, megaloblastic anemia, and iron deficiency anemia), Haemorasis detected over half a million WBC and millions of RBC and characterized their morphology. These large sets of cell morphologies can be used in diagnosis and disease subtyping, while identifying novel associations between computational morphotypes and disease. We find that hypolobulated neutrophils and large RBC are characteristic of SF3B1-mutant MDS. Additionally, while prevalent in both iron deficiency and megaloblastic anemia, hyperlobulated neutrophils are larger in the latter. By integrating cytomorphological features using machine learning, Haemorasis was able to distinguish SF3B1-mutant MDS from other MDS using cytomorphology and blood counts alone, with high predictive performance. We validate our findings externally, showing that they generalize to other centers and scanners. Collectively, our work reveals the potential for the large-scale incorporation of automated cytomorphology into routine diagnostic workflows.
Identifiants
pubmed: 37474506
doi: 10.1038/s41467-023-39676-y
pii: 10.1038/s41467-023-39676-y
pmc: PMC10359268
doi:
Banques de données
figshare
['10.6084/m9.figshare.19153760', '10.6084/m9.figshare.19164209', '10.6084/m9.figshare.19372292', '10.6084/m9.figshare.19369391', '10.6084/m9.figshare.19371008']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
4378Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C22324/A23015
Pays : United Kingdom
Informations de copyright
© 2023. The Author(s).
Références
Nat Rev Cancer. 2007 Feb;7(2):118-29
pubmed: 17251918
Int J Lab Hematol. 2022 Apr;44(2):236-247
pubmed: 34981651
Br J Haematol. 2010 Nov;151(4):359-64
pubmed: 20812999
Blood. 2020 Nov 12;136(20):2249-2262
pubmed: 32961553
IEEE Trans Pattern Anal Mach Intell. 1986 Jun;8(6):679-98
pubmed: 21869365
Blood. 1988 Feb;71(2):305-12
pubmed: 3337899
Ann Hematol. 2017 Jul;96(7):1105-1112
pubmed: 28526957
Hum Pathol. 1988 Apr;19(4):454-9
pubmed: 2835302
Leukemia. 2014 Feb;28(2):241-7
pubmed: 24220272
Blood. 2013 Nov 21;122(22):3616-27; quiz 3699
pubmed: 24030381
Nature. 2018 Jul;559(7714):400-404
pubmed: 29988082
Oncotarget. 2017 Jul 5;8(43):73483-73500
pubmed: 29088721
Br J Haematol. 2014 Aug;166(4):496-513
pubmed: 24942828
Annu Rev Med. 2005;56:1-16
pubmed: 15660498
Vnitr Lek. 2016 Fall;62(9):692-697
pubmed: 27715070
Blood. 2006 Jun 1;107(11):4205
pubmed: 16739263
Micron. 2016 Apr;83:32-41
pubmed: 26867209
Cancer. 1989 Dec 15;64(12):2506-10
pubmed: 2819658
Nat Methods. 2019 Dec;16(12):1247-1253
pubmed: 31636459
Leukemia. 2022 Jan;36(1):111-118
pubmed: 34497326
Br J Haematol. 1999 Dec;107(3):512-5
pubmed: 10583250
Br J Haematol. 1986 Aug;63(4):665-9
pubmed: 3460627
Blood. 2022 Mar 31;139(13):2038-2049
pubmed: 34861039
Blood. 2004 May 1;103(9):3265-70
pubmed: 14684416
Comput Math Methods Med. 2014;2014:979302
pubmed: 24803955
Nat Med. 2022 Oct;28(10):1996-1999
pubmed: 36097217
Blood. 2019 Mar 7;133(10):1096-1107
pubmed: 30670446
Nat Med. 2021 May;27(5):775-784
pubmed: 33990804
Blood Cancer J. 2019 Aug 9;9(8):63
pubmed: 31399557
World J Gastroenterol. 2021 May 28;27(20):2545-2575
pubmed: 34092975
Blood. 2020 Jul 9;136(2):157-170
pubmed: 32347921
Leukemia. 2014 Sep;28(9):1793-8
pubmed: 24919805
Comput Methods Programs Biomed. 2019 May;173:1-14
pubmed: 31046984
J Leukoc Biol. 2018 Sep;104(3):641-647
pubmed: 29656609
Sci Rep. 2017 Dec 4;7(1):16878
pubmed: 29203879
Blood. 2021 Nov 18;138(20):1917-1927
pubmed: 34792573
Br J Haematol. 1980 Mar;44(3):511-3
pubmed: 7378314
Blood. 2012 Sep 20;120(12):2454-65
pubmed: 22740453
Leuk Lymphoma. 2019 Dec;60(13):3161-3171
pubmed: 31111762
Eur J Cancer. 2016 Feb;54:49-56
pubmed: 26720403
Br J Haematol. 1984 Oct;58(2):227-30
pubmed: 6591944
Am J Hematol. 2020 Nov;95(11):1399-1420
pubmed: 32744763
Haematologica. 2009 Jul;94(7):994-7
pubmed: 19535346
CMAJ. 2021 Sep 7;193(35):E1391-E1394
pubmed: 34462316
Int J Lab Hematol. 2020 Aug;42(4):418-422
pubmed: 32297416
Blood. 2015 Jul 9;126(2):233-41
pubmed: 25957392
Leuk Res. 2012 Nov;36(11):1428-33
pubmed: 22921018
Blood. 2008 Jul 1;112(1):45-52
pubmed: 18443215
Postgrad Med. 1978 Oct;64(4):117-22
pubmed: 704501
Blood Cancer Discov. 2021 Mar 22;2(3):238-249
pubmed: 34661156
Nat Methods. 2019 Jan;16(1):67-70
pubmed: 30559429
N Engl J Med. 2014 Dec 25;371(26):2488-98
pubmed: 25426837
Am Fam Physician. 2009 Feb 1;79(3):203-8
pubmed: 19202968
Med Biol Eng Comput. 2020 Jun;58(6):1265-1284
pubmed: 32222951
Genome Biol. 2006;7(10):R100
pubmed: 17076895
Expert Opin Pharmacother. 2017 Aug;18(12):1213-1224
pubmed: 28675065